The Sector develops advanced methodologies for the quantification of molecular and cellular biomarkers of high clinical value. Research activities focus on the analysis of tumour markers, indicators of viral infections (e.g. SARS-CoV-2), and cell differentiation signals. To this end, cutting-edge technologies like digital and real-time PCR are employed, complemented by microscopy and spectrophotometry techniques aimed at monitoring critical cellular functions, including viability and proliferation.

The research outcomes are fundamental to the evolution of modern diagnostics, personalized medicine, and regenerative medicine. Through the development of reference materials and standardized measurement methods, the Sector actively collaborates with clinical laboratories and international metrological bodies. The goal is to enhance the reliability of biomedical measurements, ensuring clinical results that are more accurate, comparable, and with a known and rigorously calculated uncertainty.